Filing Details
- Accession Number:
- 0001628280-23-023503
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-26 18:48:06
- Reporting Period:
- 2023-06-22
- Accepted Time:
- 2023-06-26 18:48:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727207 | Accelerate Diagnostics Inc | AXDX | Laboratory Analytical Instruments (3826) | 841072256 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1784805 | Jack Phillips | C/O Accelerate Diagnostics, Inc. 3950 S. Country Club Road, Suite 470 Tucson AZ 85714 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-22 | 62,160 | $0.00 | 563,624 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-22 | 27,262 | $0.71 | 536,362 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Restricted Stock Units | Disposition | 2023-06-22 | 62,160 | $0.00 | 62,160 | $0.00 |
| Common Stock | Employee Restricted Stock Units | Acquisiton | 2023-06-26 | 3,131,579 | $0.00 | 3,131,579 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 3,131,579 | No | 4 | A | Direct |
Footnotes
- The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 RSUs, which vested in equal amounts on each anniversary date, over three years, beginning June 22, 2021 and ending on June 22, 2023.
- The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. The reporting person received 3,131,579 RSUs on June 26, 2023. 626,316 RSUs vest on June 26, 2025, 626,316 RSUs vest on July 10, 2025, 939,474 RSUs vest on June 26, 2026, and 939,473 RSUs vest on July 10, 2027. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
- Not Applicable.
Billionaire Hedge Funds
